UBS’s Vericel Corp VCEL Stock Holding History

UBS’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-175	Closed	-$1K	–	10743
2013 Q2	$1K	Buy	+175	New	+$2.1K	﹤0.01%	10042

Other funds holding VCEL

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

UBS's VCEL Position: Q3 2014 in Review

UBS increased its Vericel Corp (VCEL) stake by 19,514% in Q3 2014, buying an estimated $4.52K and bringing the position to 1,373 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #9652.

UBS first reported a position in VCEL in Q2 2013 and has held it in 6 quarters since. 31 funds tracked by Wall St. Rank hold VCEL as of Q3 2014.

UBS held 1,373 shares of Vericel Corp worth $4K as of Q3 2014.
UBS bought 1,366 Vericel Corp shares in Q3 2014, an estimated $4.52K.
Vericel Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9652 holding.
UBS first reported a position in Vericel Corp in Q2 2013 and has held it in 6 quarters since.
31 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.